Prospective Safety Cohort Study After VLA1553 Vaccination in Municipalities Selected for Participation in the VLA1553 Pilot Vaccination Strategy in Brazil

Conditions

• Chikungunya Virus Infection

Interventions

• BIOLOGICAL: Live-attenuated CHIKV vaccine VLA1553

Sponsor

Valneva Austria GmbH

Collaborators

• [object Object]
• [object Object]